Efficacy and Safety of PD-(L)1 inhibitors plus Chemotherapy versus Chemotherapy in Treatment for Triple Negative Breast Cancer：A meta-Analysis of Randomized Control Trials | Zendy

AI Assistant Blog Pricing

Efficacy and Safety of PD-(L)1 inhibitors plus Chemotherapy versus Chemotherapy in Treatment for Triple Negative Breast Cancer：A meta-Analysis of Randomized Control Trials

Details

The content you want is available to Zendy users.Already have an account? Click here. to sign in.